ME1 and ME2: The monoclonal antibodies ME1 and ME2, which were initially generated by immunizing mice with the mesothelioma cell line SPC111 [87], have been used to study human cultured mesothelial cells and ovarian tumor cells. The gene discussed is ME2; the disease is mesothelioma.